<DOC>
	<DOCNO>NCT02164929</DOCNO>
	<brief_summary>The purpose study assess effectiveness transversus abdominal plane ( TAP ) block , thoracic epidural paravertebral block ( PVB ) control postoperative pain compare opioid self-administer vein use PCA device . The primary outcome postoperative opioid consumption within 24 hour surgery . A total 120 subject randomize 1:1:1:1 ratio receive TAP block , PVB , TEA block ( PCA alone ) .Patients group care use establish enhanced recovery surgery ( ERAS ) pathway incorporate multimodal analgesic regimen use IV acetaminophen postoperative PCA fentanyl .</brief_summary>
	<brief_title>Comparison Study Transversus Abdominal Plane , Paravertebral Epidural Blocks Laparoscopic Colectomy</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Inclusion Criteria Male female , â‰¥ 18 year age Patients schedule undergo laparoscopic colectomy without stoma general anesthesia American Society Anesthesiology ( ASA ) Physical Class 13 . Open colectomy Perineal resection Stoma formation Patients contraindication TEA regional anesthesia . Pregnancy , nursing , plan become pregnant study within one month . Longacting opioid medication within 3 day . Any opioid medication within 24 hour . Body weight less 50 kilogram ( ~110 pound ) Uncontrolled anxiety , schizophrenia , psychiatric disorder Current historical evidence clinically significant disease condition , opinion Investigator , may increase risk surgery complicate subject 's postoperative course . Administration investigational drug within 30 day 5 elimination halflives investigational drug , whichever longer , prior study drug administration , plan administration another investigational product procedure subject 's participation study . Suspected , know addiction abuse illicit drug ( ) , prescription medicine ( ) , alcohol within past 2 year . Significant medical condition laboratory result , opinion Investigator , indicate increase vulnerability study drug procedure , expose subject unreasonable risk result participate clinical trial , : debilitating disease , acute illness , hypotension , partial complete conduction block , impaired cardiac function , untreated hypertension , advance arteriosclerotic heart disease , cerebral vascular insufficiency , preexist abnormal neurological neuromuscular disease ( e.g. , epilepsy , myasthenia gravis ) , advance liver disease , severe renal impairment , advanced diabetes , comorbid condition associate immunocompromised status , blood dyscrasia , HIV/AIDS , recent chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>TAP block</keyword>
	<keyword>Paravertebral block</keyword>
	<keyword>Epidural</keyword>
	<keyword>Laparoscopic colectomy</keyword>
</DOC>